Extends Gratitude to Outgoing Board Members for Their Years of Dedicated Service to the IMF BoardSTUDIO CITY, Calif., Nov. 26 ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

The FDA accepts GSK's BLA seeking approval of Blenrep combinations for treating relapsed/refractory multiple myeloma. A decision is due on July 23, 2025.

Samer A. Al’Hadidi, MD, discusses factors influencing early use of chimeric antigen receptor T-cell therapy in patients with ...

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...

Many of you may remember from this column that I have multiple myeloma, or cancer of the bone marrow. In January, I will be headed to UVA hospital for a ...

The global CAR-T Cell Therapy market size is expected to reach USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026 according to a new study published by Report Ocean. Request To ...

Researchers sought to determine whether cilta-cel would have similar results in a real-world RRMM population as in a clinical trial population.

Helen van Bueren, 77, from Derbyshire, who has Multiple Myeloma, is one of those who has lost her Winter Fuel Payment and ...

Adaptive Biotechnologies posted strong Q3 results, beating expectations and reducing losses. Read why I maintain a Hold ...

Q3 2024 Earnings Call Transcript November 25, 2024 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the ...

Maczko said her brother died in 2016 of multiple myeloma and she had other loved ones with cancer. "We started a team years ...